CellaVision AB (publ) (CEVI.ST)
SEK 163.0
(-1.21%)
SEK 163.0
(-1.21%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 126.03 Million SEK | -11.6% |
| 2022 | 142.57 Million SEK | 23.88% |
| 2021 | 115.08 Million SEK | 37.57% |
| 2020 | 83.66 Million SEK | 52.64% |
| 2019 | 54.8 Million SEK | 59.08% |
| 2018 | 34.45 Million SEK | 19.82% |
| 2017 | 28.75 Million SEK | -20.73% |
| 2016 | 36.27 Million SEK | 47.32% |
| 2015 | 24.62 Million SEK | -2.01% |
| 2014 | 25.12 Million SEK | 49.6% |
| 2013 | 16.79 Million SEK | 2.7% |
| 2012 | 16.35 Million SEK | 13.19% |
| 2011 | 14.45 Million SEK | 92.31% |
| 2010 | 7.51 Million SEK | -17.35% |
| 2009 | 9.09 Million SEK | 8.86% |
| 2008 | 8.35 Million SEK | 111.31% |
| 2007 | 3.95 Million SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 118.61 Million SEK | -2.98% |
| 2024 Q3 | 114.94 Million SEK | -3.1% |
| 2024 Q1 | 122.25 Million SEK | -3.0% |
| 2023 Q4 | 126.03 Million SEK | -9.64% |
| 2023 Q1 | 152.03 Million SEK | 6.64% |
| 2023 Q2 | 156.93 Million SEK | 3.22% |
| 2023 FY | 126.03 Million SEK | -11.6% |
| 2023 Q3 | 139.48 Million SEK | -11.12% |
| 2022 Q2 | 123.25 Million SEK | 6.35% |
| 2022 Q4 | 142.57 Million SEK | 9.53% |
| 2022 FY | 142.57 Million SEK | 23.88% |
| 2022 Q1 | 115.89 Million SEK | 0.7% |
| 2022 Q3 | 130.16 Million SEK | 5.6% |
| 2021 Q4 | 115.08 Million SEK | 11.91% |
| 2021 Q1 | 83.34 Million SEK | -0.38% |
| 2021 FY | 115.08 Million SEK | 37.57% |
| 2021 Q2 | 91.72 Million SEK | 10.06% |
| 2021 Q3 | 102.84 Million SEK | 12.12% |
| 2020 Q2 | 69.82 Million SEK | 4.87% |
| 2020 Q1 | 66.58 Million SEK | 21.49% |
| 2020 FY | 83.66 Million SEK | 52.64% |
| 2020 Q4 | 83.66 Million SEK | -2.23% |
| 2020 Q3 | 85.56 Million SEK | 22.54% |
| 2019 Q1 | 27.81 Million SEK | -19.26% |
| 2019 Q2 | 35 Million SEK | 25.81% |
| 2019 Q4 | 54.8 Million SEK | 46.44% |
| 2019 Q3 | 37.42 Million SEK | 6.93% |
| 2019 FY | 54.8 Million SEK | 59.08% |
| 2018 Q1 | 27.57 Million SEK | -4.09% |
| 2018 Q4 | 34.45 Million SEK | 25.25% |
| 2018 FY | 34.45 Million SEK | 19.82% |
| 2018 Q3 | 27.5 Million SEK | -15.56% |
| 2018 Q2 | 32.57 Million SEK | 18.12% |
| 2017 FY | 28.75 Million SEK | -20.73% |
| 2017 Q4 | 28.75 Million SEK | 0.7% |
| 2017 Q2 | 31.86 Million SEK | 1.29% |
| 2017 Q1 | 31.46 Million SEK | -13.27% |
| 2017 Q3 | 28.55 Million SEK | -10.4% |
| 2016 Q1 | 29.22 Million SEK | 18.67% |
| 2016 Q3 | 32.88 Million SEK | 6.28% |
| 2016 Q4 | 36.27 Million SEK | 10.33% |
| 2016 Q2 | 30.93 Million SEK | 5.87% |
| 2016 FY | 36.27 Million SEK | 47.32% |
| 2015 Q2 | 29.75 Million SEK | 14.48% |
| 2015 Q4 | 24.62 Million SEK | -1.56% |
| 2015 FY | 24.62 Million SEK | -2.01% |
| 2015 Q1 | 25.99 Million SEK | 3.44% |
| 2015 Q3 | 25.01 Million SEK | -15.95% |
| 2014 Q3 | 20.62 Million SEK | 26.72% |
| 2014 Q4 | 25.12 Million SEK | 21.84% |
| 2014 Q1 | 16.21 Million SEK | -3.47% |
| 2014 FY | 25.12 Million SEK | 49.6% |
| 2014 Q2 | 16.27 Million SEK | 0.38% |
| 2013 FY | 16.79 Million SEK | 2.7% |
| 2013 Q1 | 15.91 Million SEK | -2.71% |
| 2013 Q3 | 20.54 Million SEK | -12.08% |
| 2013 Q4 | 16.79 Million SEK | -18.25% |
| 2013 Q2 | 23.36 Million SEK | 46.86% |
| 2012 Q4 | 16.35 Million SEK | -3.42% |
| 2012 Q2 | 16.94 Million SEK | 3.26% |
| 2012 Q1 | 16.4 Million SEK | 13.56% |
| 2012 FY | 16.35 Million SEK | 13.19% |
| 2012 Q3 | 16.93 Million SEK | -0.05% |
| 2011 FY | 14.45 Million SEK | 92.31% |
| 2011 Q4 | 14.45 Million SEK | 72.35% |
| 2011 Q3 | 8.38 Million SEK | -8.07% |
| 2011 Q1 | 6.67 Million SEK | -11.17% |
| 2011 Q2 | 9.12 Million SEK | 36.63% |
| 2010 Q1 | 11.18 Million SEK | 23.06% |
| 2010 Q2 | 11.96 Million SEK | 6.92% |
| 2010 FY | 7.51 Million SEK | -17.35% |
| 2010 Q3 | 7.24 Million SEK | -39.4% |
| 2010 Q4 | 7.51 Million SEK | 3.67% |
| 2009 Q3 | 10.04 Million SEK | -18.39% |
| 2009 FY | 9.09 Million SEK | 8.86% |
| 2009 Q2 | 12.3 Million SEK | 0.0% |
| 2009 Q4 | 9.09 Million SEK | -9.45% |
| 2008 FY | 8.35 Million SEK | 111.31% |
| 2008 Q4 | 8.35 Million SEK | 0.0% |
| 2007 FY | 3.95 Million SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Acarix AB (publ) | 6.83 Million SEK | -1742.93% |
| ADDvise Group AB (publ) | 121.2 Million SEK | -3.992% |
| ADDvise Group AB (publ) | 121.2 Million SEK | -3.992% |
| Arcoma AB | 28.02 Million SEK | -349.702% |
| Bactiguard Holding AB (publ) | 29.64 Million SEK | -325.143% |
| BICO Group AB (publ) | 493.1 Million SEK | 74.44% |
| Boule Diagnostics AB (publ) | 62.4 Million SEK | -101.984% |
| Clinical Laserthermia Systems AB (publ) | 6.11 Million SEK | -1961.128% |
| Chordate Medical Holding AB (publ) | 1.77 Million SEK | -7017.088% |
| C-Rad AB (publ) | 64.09 Million SEK | -96.627% |
| Duearity AB (publ) | 4.15 Million SEK | -2930.488% |
| Dignitana AB (publ) | 7.41 Million SEK | -1600.229% |
| Episurf Medical AB (publ) | 3.7 Million SEK | -3306.432% |
| Getinge AB (publ) | 6.41 Billion SEK | 98.036% |
| Scandinavian Real Heart AB (Publ) | -1.68 Million SEK | 7587.238% |
| Iconovo AB (publ) | -4.86 Million SEK | 2692.308% |
| Integrum AB (publ) | 22.36 Million SEK | -463.627% |
| Luxbright AB (publ) | 8000.00 SEK | -1575375.0% |
| Mentice AB (publ) | 14.1 Million SEK | -793.633% |
| OssDsign AB (publ) | 4.3 Million SEK | -2828.392% |
| Paxman AB (publ) | 19.99 Million SEK | -530.222% |
| Promimic AB (publ) | 330 Thousand SEK | -38093.333% |
| Qlife Holding AB (publ) | 7.29 Million SEK | -1628.442% |
| SciBase Holding AB (publ) | 11.91 Million SEK | -957.454% |
| ScandiDos AB (publ) | 22.69 Million SEK | -455.478% |
| Sectra AB (publ) | 36.59 Million SEK | -244.46% |
| Sedana Medical AB (publ) | 42.97 Million SEK | -193.282% |
| Senzime AB (publ) | 20.34 Million SEK | -519.656% |
| SpectraCure AB (publ) | 1.00 SEK | -12603799900.0% |
| Stille AB | 66.55 Million SEK | -89.38% |
| Vitrolife AB (publ) | 413 Million SEK | 69.482% |
| Xvivo Perfusion AB (publ) | 141.6 Million SEK | 10.993% |